Page 4 - CIRN Annual Report 2017-18

CIRN | 2018 ANNUAL REPORT

Network LEADS

DR. SCOTT HALPERIN
NOMINATED PRINCIPAL INVESTIGATOR, CIRN

Director of the Canadian Center for Vaccinology, Dr. Halperin is a Professor
of Pediatrics and Microbiology and Immunology at Dalhousie University,
Head of Pediatric Infectious Diseases at the IWK Health Centre in Halifax.
He is the Director of the Canadian Center for Vaccinology (CCfV) in Halifax,
NS. He is also the Co-PI for the Immunization Monitoring Program, Active
(IMPACT) and a member of CAIRE’s Management Committee. His research
focuses on the diagnosis, treatment, and prevention of pertussis and other
vaccine-preventable diseases.

DR. JULIE BETTINGER, DR. JOANNE LANGLEY, DR. SHELLY MCNEIL,
NETWORK LEAD, CANADIAN NETWORK LEAD, CLINICAL NETWORK CO-LEAD,
NATIONAL VACCINE SAFETY TRIALS NETWORK SERIOUS OUTCOMES
NETWORK SURVEILLANCE NETWORK
Dr. Joanne Langley is a Professor of
Dr. Julie Bettinger is an Associate Pediatrics and Community Health Dr. Shelly McNeil a Clinical Research
Professor at the Vaccine Evaluation and Epidemiology at Dalhousie Scholar, Dalhousie University and
Center in the Department of University, the CIHR-GSK Chair in Chief, Division Infectious Diseases
Pediatrics at the University of British Pediatric Vaccinology, and Associate at the Nova Scotia Health Authority.
Columbia and a Michael Smith Director of the Canadian Center She is also the Deputy Director of the
Foundation for Health Research for Vaccinology. Her main research Canadian Center for Vaccinology. Her
Scholar. Her research interests interests are in the epidemiology and research focuses on immunization
include vaccine safety and vaccine prevention of respiratory infections. policy, evaluation of the epidemiology
preventable diseases as well of vaccine-preventable diseases in
as attitudes and beliefs around adults with a focus on the elderly
immunization uptake and use. and pregnant women, as well as the
assessment of the effectiveness of
vaccines in the prevention of serious
outcomes in adults and clinical
trials of new vaccines targeted at
adolescent and adult populations.